Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres

Tissue Engineering

Volumn 13, Issue 1, 2007, Pages 147-158

  Nagae, Masateru ^a   Ikeda, Takumi ^a   Mikami, Yasuo ^a   Hase, Hitoshi ^a   Ozawa, Hitoshi ^b   Matsuda, Ken Ichi ^a   Sakamoto, Hirotaka ^a   Tabata, Yasuhiko ^c   Kawata, Mitsuhiro ^a   Kubo, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; BIODIVERSITY; HISTOLOGY; HYDROGELS; PHYSICAL CHEMISTRY; PROTEINS;

NUCLEUS PULPOSUS (NP); PHOSPHATE-BUFFERED SALINE (PBS); PLATELET-RICH PLASMA (PRP); THERAPEUTIC MODALITY;

PLASMAS;

GELATIN; GROWTH FACTOR; MICROSPHERE; PHOSPHATE BUFFERED SALINE; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARTILAGE DEGENERATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERVERTEBRAL DISK; NONHUMAN; NUCLEUS PULPOSUS; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION;

ABSORBABLE IMPLANTS; ANIMALS; BONE REGENERATION; DRUG DELIVERY SYSTEMS; GELATIN; HYDROGELS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DISPLACEMENT; MALE; MICROSPHERES; PLATELET COUNT; PLATELET-RICH PLASMA; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 33846644391     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0042     Document Type: Conference Paper

References (60)

1. Waddell, G. Low back pain: a twentieth century health care enigma. Spine 21, 2820, 1996.
2. Williams, D.A., Feuerstein, M., Durbin, D., and Pezzullo, J. Health care and indemnity costs across the natural history of disability in occupational low back pain. Spine 23, 2329, 1998.
3. Ekman, M., Johnell, O., and Lidgren, L. The economic cost of low back pain in Sweden in 2001. Acta Orthop. 76, 275, 2005.
4. Andersson, G.B. Epidemiological features of chronic low-back pain. Lancet 354, 581, 1999.
5. Biyani, A., and Andersson, G.B. Low back pain: pathophysiology and management. J. Am. Acad. Orthop. Surg. 12, 106, 2004.
6. Urban, J.P., and McMullin, J.F. Swelling pressure of the lumbar intervertebral discs: influence of age, spinal level, composition, and degeneration. Spine 13, 179, 1988.
7. Johnstone, B., Urban, J.P., Roberts, S., and Menage, J. The fluid content of the human intervertebral disc. Comparison between fluid content and swelling pressure profiles of discs removed at surgery and those taken postmortem. Spine 17, 412, 1992.
8. Marchand, F., and Ahmed, A.M. Investigation of the laminate structure of lumbar disc annulus fibrosus. Spine 15, 402, 1990.
9. Humzah, M.D., and Soames, R.W. Human intervertebral disc: structure and function. Anat. Rec. 220, 337, 1988.
10. Lipson, S.J., and Muir, H. Experimental intervertebral disc degeneration: morphologic and proteoglycan changes over time. Arthritis Rheum. 24, 12, 1981.
11. Thompson, J.P., Oegema, T.R. Jr., and Bradford, D.S. Stimulation of mature canine intervertebral disc by growth factors. Spine 16, 253, 1991.
12. Osada, R., Ohshima, H., Ishihara, H., Yudoh, K., Sakai, K., Matsui, H., and Tsuji, H. Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J. Orthop. Res. 14, 690, 1996.
13. Gruber, H.E., Fisher, E.G. Jr., Desai, B., Stasky, A.A., Hoelscher, G., and Hanley, E.N. Jr. Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. Exp. Cell. Res. 235, 13, 1997.
14. Gruber, H.E., Norton, H.J., and Hanley, E.N. Jr. Antiapoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. Spine 25, 2153, 2000.
15. Takegami, K., Thonar, E.J., An, H.S., Kamada, H., and Masuda, K. Osteogenic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-1. Spine 27, 1318, 2002.
16. Alini, M., Li, W., Markovic, P., Aebi, M., Spiro, R.C., and Roughley, P.J. The potential and limitations of a cell-seeded collagen/hyaluronan scaffold to engineer an intervertebral disc-like matrix. Spine 28, 446, 2003.
17. Kim, D.J., Moon, S.H., Kim, H., Kwon, U.H., Park, M.S., Han, K.J., Hahn, S.B., and Lee, H.M. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine 28, 2679, 2003.
18. Masuda, K., Takegami, K., An, H., Kumano, F., Chiba, K., Andersson, G.B., Schmid, T., and Thonar, E. Recombinant osteogenic protein-1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads. J. Orthop. Res. 21, 922, 2003.
19. Risbud, M.V., Izzo, M.W., Adams, C.S., Arnold, W.W., Hillibrand, A.S., Vresilovic, E.J., Vaccaro, A.R., Albert, T.J., and Shapiro, I.M. An organ culture system for the study of the nucleus pulposus: description of the system and evaluation of the cells. Spine 28, 2652, 2003.
20. Yoon, S.T., Kim, K.S., Li, J., Park, J.S., Akamaru, T., Elmer, W.A., and Hutton, W.C. The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine 28, 1773, 2003.
21. Takegami, K., An, H.S., Kumano, F., Chiba, K., Thonar, E.J., Singh, K., and Masuda, K. Osteogenic protein-1 is most effective in stimulating nucleus pulposus and annulus fibrosus cells to repair their matrix after chondroitinase ABC-induced in vitro chemonucleolysis. Spine J. 5, 231, 2005.
22. Marx, R.E. Platelet-rich plasma: evidence to support its use. J. Oral Maxillofac. Surg. 62, 489, 2004.
23. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 85, 638, 1998.
24. Weibrich, G., Kleis, W.K., Hafner, G., and Hitzler, W.E. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J. Craniomaxillofac. Surg. 30, 97, 2002.
25. Okuda, K., Kawase, T., Momose, M., Murata, M., Saito, Y., Suzuki, H., Wolff, L.F., and Yoshie, H. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J. Periodontol. 74, 849, 2003.
26. Eppley, B.L., Woodell, J.E., and Higgins, J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast. Reconstr. Surg. 114, 1502, 2004.
27. Tabata, Y., Hijikata, S., Muniruzzaman, M., and Ikada, Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J. Biomater. Sci. Polym. Ed. 10, 79, 1999.
28. Okuma, M., Mochida, J., Nishimura, K., Sakabe, K., and Seiki, K. Reinsertion of stimulated nucleus pulposus cells retards intervertebral disc degeneration: an in vitro and in vivo experimental study. J. Orthop. Res. 18, 988, 2000.
29. Nomura, T., Mochida, J., Okuma, M., Nishimura, K., and Sakabe, K. Nucleus pulposus allograft retards intervertebral disc degeneration. Clin. Orthop. Relat. Res. 389, 94, 2001.
30. Nishimura, K., and Mochida, J. Percutaneous reinsertion of the nucleus pulposus. An experimental study. Spine 23, 1531, 1998.
31. Mazor, Z., Peleg, M., Garg, A.K., and Luboshitz, J. Platelet-rich plasma for bone graft enhancement in sinus floor augmentation with simultaneous implant placement: patient series study. Implant Dent. 13, 65, 2004.
32. Oyama, T., Nishimoto, S., Tsugawa, T., and Shimizu, F. Efficacy of platelet-rich plasma in alveolar bone grafting. J. Oral Maxillofac. Surg. 62, 555, 2004.
33. Puolakkainen, P.A., Twardzik, D.R., Ranchalis, J.E., Pankey, S.C., Reed, M.J., and Gombotz, W.R. The enhancement in wound healing by transforming growth factor-beta 1 (TGF-beta1) depends on the topical delivery system. J. Surg. Res. 58, 321, 1995.
34. Lee, S.J. Cytokine delivery and tissue engineering. Yonsei Med J. 41, 704, 2000.
35. Nishida, K., Kang, J.D., Gilbertson, L.G., Moon, S.H., Suh, J.K., Vogt, M.T., Robbins, P.D., and Evans, C.H. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine 24, 2419, 1999.
36. Walsh, A.J., Bradford, D.S., and Lotz, J.C. In vivo growth factor treatment of degenerated intervertebral discs. Spine 29, 156, 2004.
37. An, H.S., Takegami, K., Kamada, H., Nguyen, C.M., Thonar, E.J., Singh, K., Andersson, G.B., and Masuda, K. Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine 30, 25, 2005.
38. Kawakami, M., Matsumoto, T., Hashizume, H., Kuribayashi, K., Chubinskaya, S., and Yoshida, M. Osteogenic protein-1 (osteogenic protein-1/bone morphogenetic protein-7) inhibits degeneration and pain-related behavior induced by chronically compressed nucleus pulposus in the rat. Spine 30, 1933, 2005.
39. Masuda, K., Imai, Y., Okuma, M., Muehleman, C., Nakagawa, K., Akeda, K., Thonar, E., Andersson, G., and An, H. S. Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit annular puncture model. Spine 31, 742, 2006.
40. Roberts, S., Menage, J., Duance, V., Wotton, S., and Ayad, S. 1991 Volvo Award in basic sciences. Collagen types around the cells of the intervertebral disc and cartilage end plate: an immunolocalization study. Spine 16, 1030, 1991.
41. Tabata, Y., and Ikada, Y. Protein release from gelatin matrices. Adv. Drug Deliv. Rev. 31, 287, 1998.
42. Tabata, Y., Nagano, A., and Ikada, Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng. 5, 127, 1999.
43. Ozeki, M., and Tabata, Y. Promoted growth of murine hair follicles through controlled release of basic fibroblast growth factor. Tissue Eng. 8, 359, 2002.
44. Yamamoto, M., Tabata, Y., Hong, L., Miyamoto, S., Hashimoto, N., and Ikada, Y. Bone regeneration by transforming growth factor beta1 released from a biodegradable hydrogel. J. Control. Release 64, 133, 2000.
45. Hong, L., Tabata, Y., Miyamoto, S., Yamamoto, M., Yamada, K., Hashimoto, N., and Ikada, Y. Bone regeneration at rabbit skull defects treated with transforming growth factor-beta1 incorporated into hydrogels with different levels of biodegradability. J. Neurosurg. 92, 315, 2000.
46. Kanematsu, A., Yamamoto, S., Ozeki, M., Noguchi, T., Kanatani, I., Ogawa, O., and Tabata, Y. Collagenous matrices as release carriers of exogenous growth factors. Biomaterials 25, 4513, 2004.
47. Yamamoto, M., Takahashi, Y., and Tabata, Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24, 4375, 2003.
48. Hokugo, A., Ozeki, M., Kawakami, O., Sugimoto, K., Mushimoto, K., Morita, S., and Tabata, Y. Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng. 11, 1224, 2005.
49. Yazawa, M., Ogata, H., Nakajima, T., Mori, T., Watanabe, N., and Handa, M. Basic studies on the clinical applications of platelet-rich plasma. Cell Transplant. 12, 509, 2003.
50. Sakai, D., Mochida, J., Yamamoto, Y., Nomura, T., Okuma, M., Nishimura, K., Nakai, T., Ando, K., and Hotta, T. Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: a potential therapeutic model for disc degeneration. Biomaterials 24, 3531, 2003.
51. Urban, J.P., and McMullin, J.F. Swelling pressure of the intervertebral disc: influence of proteoglycan and collagen contents. Biorheology 22, 145, 1985.
52. Ohshima, H., Tsuji, H., Hirano, N., Ishihara, H., Katoh, Y., and Yamada, H. Water diffusion pathway, swelling pressure, and biomechanical properties of the intervertebral disc during compression load. Spine 14, 1234, 1989.
53. Pearce, R.H., Grimmer, B.J., and Adams, M.E. Degeneration and the chemical composition of the human lumbar intervertebral disc. J. Orthop. Res. 5, 198, 1987.
54. Roughley, P.J., Alini, M., and Antoniou, J. The role of proteoglycans in aging, degeneration and repair of the intervertebral disc. Biochem. Soc. Trans. 30, 869, 2002.
55. Oegema, T.R. Jr. Biochemistry of the intervertebral disc. Clin. Sports Med. 12, 419, 1993.
56. Masuda, K., Oegema, T.R. Jr., and An, H.S. Growth factors and treatment of intervertebral disc degeneration. Spine 29, 2757, 2004.
57. Akeda, K., An, H.S., Pichika, R., Attawia, M., Thonar, E.J., Lenz, M.E., Uchida, A., and Masuda, K. Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine 31, 959, 2006.
58. Trout, J.J., Buckwalter, J.A., Moore, K.C., and Landas, S.K. Ultrastructure of the human intervertebral disc. I. Changes in notochordal cells with age. Tissue Cell 14, 359, 1982.
59. Sobajima, S., Kompel, J.F., Kim, J.S., Wallach, C.J., Robertson, D.D., Vogt, M. T., Kang, J.D., and Gilbertson, L.G. A slowly progressive and reproducible animal model of intervertebral disc degeneration characterized by MRI, X-ray, and histology. Spine 30, 15, 2005.
60. Kim, K.S., Yoon, S.T., Li, J., Park, J.S., and Hutton, W.C. Disc degeneration in the rabbit: a biochemical and radiological comparison between four disc injury models. Spine 30, 33, 2005.